Hutch News
Results per Page:
Selective stimulation of neoantigen-specific T cells by immunotherapy
From the Riddell Lab, Clinical Research Division
Fred Hutch Evergreen Fund awards six grants to promising projects
Scientists receive up to $200K to boost research for projects deemed to have partnership potential
Scientists show thin metal mesh loaded with T cells shrinks solid tumors
Within weeks, CAR T cells targeting ovarian cancer cleared tumors in 70% of treated mice, shows study in Nature Biomedical Engineering. (Note: Images available for media use.)
Gimme shelter: CRISPR hides healthy cells from leukemia drug
In mouse study, gene-edited cells stay safe as immunotherapy attacks cancer
Dr. Martin 'Mac' Cheever, cancer immunotherapy expert, receives distinguished service award
Honor recognizes his work establishing Cancer Immunotherapy Trials Network
New program to fast-track lung cancer research from lab to clinic
Patient-focused science at the heart of $13M National Cancer Institute grant
New Research Identifies Gene That Hides Cancer Cells from Immunotherapy
Findings in Developmental Cell show that expression of an early developmental gene prevents the immune system from identifying and attacking cancer cells
Dr. Tijana Martinov named a 2019 Parker Scholar
Early-career scientist will use funding for immunotherapy research in multiple myeloma
Fred Hutch collaborates with new Allen Institute for Immunology
Multi-collaborator initiative aims to map the immune system in health and disease
Colette Chaney named ‘2018 Nurse of the Year for Research Advancement’
March of Dimes Washington honors the longtime immunotherapy clinical research nurse
Hutch science featured at world's premier cancer immunotherapy meeting
Researchers honored at SITC 2018 for work on immune-based treatments for leukemia, ovarian cancer, skin cancer
Nanoparticles open doors to cancer-fighting CAR T cells
Tiny liposome-based drug carriers make tumors more vulnerable to targeted immunotherapy
For cancer patients with HIV, immunotherapy appears safe
Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials
Science without borders
At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases
Good News: Dr. Jen Adair speaks on gene therapy at TEDxNashville
Celebrating faculty and staff achievements
Dr. Hootie Warren takes helm of Fred Hutch Global Oncology
Immunotherapy researcher, cancer doctor set to lead a new worldwide revolution in care
Good News: Researchers create a 'Rosetta Stone' to decode immune recognition
Celebrating faculty and staff achievements
Good News: Bezos family funding accelerates glioma immunotherapy research
Celebrating faculty and staff achievements
Bezos family gives $35 million to Fred Hutch
Transformative investment will be used to hire more world-class researchers to launch innovative approaches to curing cancer, said Fred Hutch President and Director Gilliland